Bioventus Signs Contract with UnitedHealthcare Commercial Plans

Bioventus agreed to a U.S. contract with UnitedHealthcare Employer & Individual commercial plans. In October, UnitedHealthcare commercial plan members will have access to DUROLANE and GELSYN-3 to treat knee osteoarthritis pain. DUROLANE is a single-injection and GELSYN-3, a three-injection hyaluronic acid-based joint-fluid treatment for...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us